Gene · 6281
NIH grants2,552
NIH projects whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 2,552
Download this page as JSON| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| R01HL117913 | The NOTCH Signaling Pathway in Large Vessel Vasculitis | 2 | 2025 |
| R01HL130020 | Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | 2 | 2025 |
| R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 2 | 2025 |
| R01MH104559 | ROLE OF PERIPHERAL IMMUNE-DERIVED MMP8 IN STRESS SUSCEPTIBILITY | 2 | 2025 |
| R35GM122510 | Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution | 2 | 2025 |
| R35GM131754 | Structural mechanism of DNA replication | 2 | 2025 |
| R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 2 | 2025 |
| R35HL155657 | Tissue factor-dependent coagulation in thrombosis and immune responses | 2 | 2025 |
| R37AI044828 | Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | 2 | 2025 |
| R37AI063331 | Cryopyrin/NLRP3 Signaling in Inflammation and Innate Immunity | 2 | 2025 |
| R37AI116550 | Defining the pathways activated by Toll-like Receptors to stimulate immunity | 2 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 2 | 2025 |
| T32AI060537 | Integrative Microbiology Program | 2 | 2025 |
| T32AI089474 | Immunology Training Program-Predoctoral | 2 | 2025 |
| U19AI057229 | Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | 2 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 2 | 2025 |
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 2 | 2025 |
| ZIABC005598 | Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells | 2 | 2025 |
| ZIABC010830 | Mechanisms of non-classical multidrug resistance in cancer | 2 | 2025 |
| ZIABC010984 | Adoptive Cell Transfer Immunotherapy of Cancer | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.1.0
Sources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/grants?page=4